Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Thiamine Mononitrate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Population Health Research Institute | Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable
COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
Details : Thiamine Mononitrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Failure.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 24, 2023
Lead Product(s) : Thiamine Mononitrate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Population Health Research Institute | Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable